Portage Biotech Has Approved A Reverse Stock Split Of 1-for-20, Effective August 15
Portfolio Pulse from Benzinga Newsdesk
Portage Biotech has approved a reverse stock split of 1-for-20, effective August 15.
August 13, 2024 | 11:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Portage Biotech has approved a reverse stock split of 1-for-20, effective August 15. This action is likely to impact the stock price in the short term.
A reverse stock split consolidates the number of existing shares into fewer, proportionally more valuable shares. This can often lead to short-term volatility as the market adjusts to the new share structure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100